Zhang C, Ma Y, Zhao Y, Guo N, Han C, Wu Q
Front Pharmacol. 2024; 15:1356112.
PMID: 38375039
PMC: 10875093.
DOI: 10.3389/fphar.2024.1356112.
Metwally E, Al-Abbadi H, Hussain T, Murtaza G, Abdellatif A, Ahmed M
Front Vet Sci. 2023; 10:1235163.
PMID: 37732142
PMC: 10507866.
DOI: 10.3389/fvets.2023.1235163.
Naylor D
Epilepsia Open. 2023; 8 Suppl 1:S35-S65.
PMID: 36861477
PMC: 10173858.
DOI: 10.1002/epi4.12718.
Chapman C, Nuwer J, Jacob T
Front Synaptic Neurosci. 2022; 14:911020.
PMID: 35663370
PMC: 9160301.
DOI: 10.3389/fnsyn.2022.911020.
Yu C, Bondada V, Joshi A, Reneer D, Telling G, Saatman K
J Neurotrauma. 2020; 37(21):2268-2276.
PMID: 32718209
PMC: 7585603.
DOI: 10.1089/neu.2020.7122.
Calcium-Activated Calpain Specifically Cleaves Glutamate Receptor IIA But Not IIB at the Neuromuscular Junction.
Metwally E, Zhao G, Li W, Wang Q, Zhang Y
J Neurosci. 2019; 39(15):2776-2791.
PMID: 30705102
PMC: 6462441.
DOI: 10.1523/JNEUROSCI.2213-17.2019.
Mitofusin 2 Regulates Axonal Transport of Calpastatin to Prevent Neuromuscular Synaptic Elimination in Skeletal Muscles.
Wang L, Gao J, Liu J, Siedlak S, Torres S, Fujioka H
Cell Metab. 2018; 28(3):400-414.e8.
PMID: 30017354
PMC: 6125186.
DOI: 10.1016/j.cmet.2018.06.011.
Regulatory role of calpain in neuronal death.
Cheng S, Wang S, Lei M, Wang Z, Xiong K
Neural Regen Res. 2018; 13(3):556-562.
PMID: 29623944
PMC: 5900522.
DOI: 10.4103/1673-5374.228762.
Environmental Enrichment Mitigates Deficits after Repetitive Mild Traumatic Brain Injury.
Liu X, Qiu J, Alcon S, Hashim J, Meehan 3rd W, Mannix R
J Neurotrauma. 2017; 34(16):2445-2455.
PMID: 28376667
PMC: 5563861.
DOI: 10.1089/neu.2016.4823.
Differential role of calpain-dependent protein cleavage in intermediate and long-term operant memory in Aplysia.
Lyons L, Gardner J, Lentsch C, Gandour C, Krishnan H, Noakes E
Neurobiol Learn Mem. 2016; 137:134-141.
PMID: 27913293
PMC: 6179366.
DOI: 10.1016/j.nlm.2016.11.018.
Activity- and development-dependent down-regulation of TARPγ8 and GluA1 in cultured rat hippocampal neurons.
Wang J, Wang Y, Xu F, Zhao J, Zhou S, Yu Y
Acta Pharmacol Sin. 2016; 37(3):303-11.
PMID: 26725511
PMC: 4775841.
DOI: 10.1038/aps.2015.112.
Physiological Roles of Calpain 1 Associated to Multiprotein NMDA Receptor Complex.
Averna M, Pellegrini M, Cervetto C, Pedrazzi M, Bavestrello M, De Tullio R
PLoS One. 2015; 10(10):e0139750.
PMID: 26431040
PMC: 4592069.
DOI: 10.1371/journal.pone.0139750.
Researching glutamate - induced cytotoxicity in different cell lines: a comparative/collective analysis/study.
Kritis A, Stamoula E, Paniskaki K, Vavilis T
Front Cell Neurosci. 2015; 9:91.
PMID: 25852482
PMC: 4362409.
DOI: 10.3389/fncel.2015.00091.
MFN2 couples glutamate excitotoxicity and mitochondrial dysfunction in motor neurons.
Wang W, Zhang F, Li L, Tang F, Siedlak S, Fujioka H
J Biol Chem. 2014; 290(1):168-82.
PMID: 25416777
PMC: 4281719.
DOI: 10.1074/jbc.M114.617167.
FRET-FLIM investigation of PSD95-NMDA receptor interaction in dendritic spines; control by calpain, CaMKII and Src family kinase.
Dore K, Labrecque S, Tardif C, De Koninck P
PLoS One. 2014; 9(11):e112170.
PMID: 25393018
PMC: 4230936.
DOI: 10.1371/journal.pone.0112170.
K-Cl cotransporter KCC2--a moonlighting protein in excitatory and inhibitory synapse development and function.
Blaesse P, Schmidt T
Pflugers Arch. 2014; 467(4):615-24.
PMID: 24909111
DOI: 10.1007/s00424-014-1547-6.
Conditional disruption of calpain in the CNS alters dendrite morphology, impairs LTP, and promotes neuronal survival following injury.
Amini M, Ma C, Farazifard R, Zhu G, Zhang Y, Vanderluit J
J Neurosci. 2013; 33(13):5773-84.
PMID: 23536090
PMC: 4153560.
DOI: 10.1523/JNEUROSCI.4247-12.2013.
Calpain 1 knockdown improves tissue sparing and functional outcomes after spinal cord injury in rats.
Yu C, Li Y, Raza K, Yu X, Ghoshal S, Geddes J
J Neurotrauma. 2012; 30(6):427-33.
PMID: 23102374
PMC: 4169127.
DOI: 10.1089/neu.2012.2561.
The NMDA receptor as a target for cognitive enhancement.
Collingridge G, Volianskis A, Bannister N, France G, Hanna L, Mercier M
Neuropharmacology. 2012; 64:13-26.
PMID: 22796429
PMC: 4696548.
DOI: 10.1016/j.neuropharm.2012.06.051.